Skip to content ↓

Swift asks MIT's DiFava, Widnall for help

Acting Governor Jane Swift has asked incoming MIT police chief John DiFava and Institute Professor Sheila Widnall for help in the aftermath of the Sept. 11 attacks.

Swift announced Tuesday that she has asked DiFava to extend his tenure as the State Police's colonel/superin-tendent for 45 days.

"Col. DiFava has been a steady presence at this difficult time in the state's history and we are very pleased that he has agreed to remain in place for the time being," Swift said in a televised speech. "The colonel has been at the center of our public safety actions since the day of the attack. His expertise will be invaluable as we continue to adjust to the post-Sept. 11 era."

President Charles M. Vest said, "We're pleased MIT can be helpful in these critical times. We look forward to John DiFava joining our community when this assignment is completed."

DiFava, who was scheduled to start at MIT on Oct. 15, is now expected to be on campus in early December. Capt. John Driscoll has been the acting chief since Anne P. Glavin stepped down in March to become MIT's director of public safety.

Last week, Swift also named Institute Professor Sheila E. Widnall to a six-member panel of experts that will recommend reforms in the operation of Logan Airport. Widnall served as Secretary of the Air Force in the Clinton administration from 1993-97.

A version of this article appeared in MIT Tech Talk on October 3, 2001.

Related Topics

More MIT News

Rich Nielsen, Volha Charnysh, Kevin Dorst, and Emily Richmond Pollock seated at a table, talking

Building a scholarly community

The SHASS Faculty Fellows Program, administered by the MIT Human Insight Collaborative, is fostering new research projects and creating space for supportive and interdisciplinary discussion.

Read full story

Globular blue and white orbs "examining" single-stranded RNA products and marking them with green checks or red x's

Why are some bacterial genes high in purines?

In certain species of bacteria, the answer lies in shielding RNA transcripts from a quality-control factor called Rho. Understanding the requirements for expressible sequences is critical for expression engineering of therapeutic agents.

Read full story